Western Wealth Management »

Aurinia Pharmaceuticals shares owned by Western Wealth Management

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Western Wealth Management from 13F filings

Historical chart of Western Wealth Management investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Western Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Western Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $147k 20k 7.33
2022-06-30 $269k 27k 10.09
2022-03-31 $338k 27k 12.40

More positions owned by Western Wealth Management

Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Core S&p500 Etf (IVV)
First Tr Exchange-traded Risng Divd Achiv (RDVY)

View all positions for Western Wealth Management

Top funds holding Aurinia Pharmaceuticals

Armistice Capital
BlackRock
BlackRock
Tang Capital Management
NEA Management Company
State Street Corporation
Goldman Sachs Group
Nuveen Asset Management
Geode Capital Management
Vanguard Group
Rock Springs Capital Management
Susquehanna International
Citadel Advisors
Schroder Investment Management Group
Northern Trust

View all funds holding Aurinia Pharmaceuticals